HitGenInc's profile picture. Advancing innovative drug discovery.

HitGen

@HitGenInc

Advancing innovative drug discovery.

HitGen reposted

Next week at a @HitGenInc webinar, BioAge SVP-Research @rmontonio will describe how we used DNA-encoded libraries to discover novel inhibitors of NLRP3, which we are developing for diseases driven by neuroinflammation. 📅 6/17/24 2pm ET 👉🏼 Register: xtalks.com/webinars/evolv…

bioagelabs's tweet image. Next week at a @HitGenInc webinar, BioAge SVP-Research @rmontonio will describe how we used DNA-encoded libraries to discover novel inhibitors of NLRP3, which we are developing for diseases driven by neuroinflammation.

📅 6/17/24  2pm ET

👉🏼 Register: xtalks.com/webinars/evolv…

HitGen reposted

💡 Join @HitGenInc's webinar on DNA-encoded libraries in early-stage drug discovery, targeting G protein-coupled receptors (#GPCRs). 🧬 Experts will discuss advantages, platforms, and applications. Learn more + register: buff.ly/3LcA5lT #SmallMolecule #DrugDevelopment

Xtalks's tweet image. 💡 Join @HitGenInc's webinar on DNA-encoded libraries in early-stage drug discovery, targeting G protein-coupled receptors (#GPCRs). 🧬  Experts will discuss advantages, platforms, and applications. Learn more + register: buff.ly/3LcA5lT

#SmallMolecule #DrugDevelopment

HitGen reposted

Jing Feng and Guansai Liu (@HitGenInc) provide an overview of cyclizations performed on-DNA as a strategy for preparing highly diverse DNA-encoded libraries #ScienceOfSynthesis (Eds. J. Scheuermann and Y. Li) 🤓 📖 brnw.ch/21wJ5o3

thiemechemistry's tweet image. Jing Feng and Guansai Liu (@HitGenInc) provide an overview of cyclizations performed on-DNA as a strategy for preparing highly diverse DNA-encoded libraries #ScienceOfSynthesis (Eds. J. Scheuermann and Y. Li) 🤓

📖 brnw.ch/21wJ5o3

HitGen reposted

Thrilled to welcome ⁦@HitGenInc⁩ as a new #sponsor! Residents from ⁦@BiolabsLA⁩ enjoyed a #lunchandlearn today about HitGen's impressive DNA-encoded library and extensive services. We're excited for this new partnership! #Biotech #Lifescience linkedin.com/posts/biolabsl…


Vernalis, a HitGen Company, announces a drug discovery collaboration in oncology with Hox Therapeutics. vernalis.com/hox-therapeuti…

HitGenInc's tweet image. Vernalis, a HitGen Company, announces a drug discovery collaboration in oncology with Hox Therapeutics. vernalis.com/hox-therapeuti…

Vernalis, a HitGen Company, announces a drug discovery collaboration in oncology with @PierreFabre Laboratories. vernalis.com/pierre-fabre-l…

HitGenInc's tweet image. Vernalis, a HitGen Company, announces a drug discovery collaboration in oncology with @PierreFabre Laboratories. vernalis.com/pierre-fabre-l…

Learn how 500+ partners use HitGen's world leading DEL technology to accelerate drug discovery. Register here: webinars.endpts.com/evolving-dna-e…

HitGenInc's tweet image. Learn how 500+ partners use HitGen's world leading DEL technology to accelerate drug discovery. Register here: webinars.endpts.com/evolving-dna-e…

HitGen reposted

We are glad to announce our #partnership with @HitGenInc, a world leader in the development of DNA-encoded library (DEL) technology for early-stage small molecule #drugdiscovery. Together we will utilize their technology platform to screen under-represented targets.

thesgconline's tweet image. We are glad to announce our #partnership with @HitGenInc, a world leader in the development of DNA-encoded library (DEL) technology for early-stage small molecule #drugdiscovery. Together we will utilize their technology platform to screen under-represented targets.

Our Vernalis Director of BD and Research Fellow, Dr Ben Davis, looks forward to connecting with friends at the @Undruggable TPD Europe Summit this week.

HitGenInc's tweet image. Our Vernalis Director of BD and Research Fellow, Dr Ben Davis, looks forward to connecting with friends at the @Undruggable TPD Europe Summit this week.

HitGen reposted

Thanks everyone for joining the Chemspace & HitGen webinar yesterday! For those who didn’t have a chance to connect, the recording is already available on Chemspace YouTube channel: youtu.be/fNtBCq0rzt8 . #chemspace #organicchemistry #drugsynthesis #research #drugdiscovery

Chem_space's tweet card. Advancing Fully Open Access OpenDEL as a Self serve DEL Kit #Chemsp...

youtube.com

YouTube

Advancing Fully Open Access OpenDEL as a Self serve DEL Kit #Chemsp...


HitGen reposted

The Speaker is Dr. Guansai Liu, Vice President at Hitgen Inc. Hosted is Dr. Olga Tarkhanova.Register via the link now! tinyurl.com/53sz7d2r . #chemspace #drugdiscovery #openscience #chemicals #organicchemistry #drugsynthesis #research #onlinewebinar

Chem_space's tweet image. The Speaker is Dr. Guansai Liu, Vice President at Hitgen Inc. Hosted is Dr. Olga Tarkhanova.Register via the link now! tinyurl.com/53sz7d2r
.
#chemspace #drugdiscovery #openscience #chemicals #organicchemistry #drugsynthesis #research #onlinewebinar

Proud to share our HitGen research team’s publication in targeted protein degradation (TPD) - Editor’s Choice in ACS Chemical Biology.

New Editor's Choice 🏅 article from #ACSChemBiol! Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach Read for free 👉 go.acs.org/3rB

ACSBioMed's tweet image. New Editor's Choice 🏅 article from #ACSChemBiol!

Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach

Read for free 👉 go.acs.org/3rB


HitGen reposted

DNA-encoded libraries + photo-activated capture = fast fragment screens. Researchers at Vernalis and @HitGenInc also add a competition assay to minimize false positives practicalfragments.blogspot.com/2022/09/fbld-m… @RoySocChem


HitGen reposted

Fragment screening paying no heed to solubility and using 1nM protein done in 1-2 weeks?!?! Pinch me now! Amazing workflow combining fragments, DEL and covalent tethering coming out of Vernalis presented by Rod Hubbard at #EFMCISMC22

BeatriceChiew's tweet image. Fragment screening paying no heed to solubility and using 1nM protein  done in 1-2 weeks?!?! Pinch me now! Amazing workflow combining fragments, DEL and covalent tethering coming out of Vernalis presented by Rod Hubbard at #EFMCISMC22

HitGen reposted

The new updated version of OpenDEL by HitGen is available on the website! Follow the link to read the full description: cutt.ly/mXZlf5B #chemspace #organicchemistry #drugsynthesis #science #openscience #research #drugdiscovery #chemicals

Chem_space's tweet image. The new updated version of OpenDEL by HitGen is available on the website! Follow the link to read the full description: cutt.ly/mXZlf5B

#chemspace #organicchemistry #drugsynthesis #science #openscience #research #drugdiscovery #chemicals

Tune in for our @endpts webinar today, moderated by @AKAarsalan on how HitGen's self-service #OpenDEL can accelerate your research. Register here: webinars.endpts.com/how-could-an-o…

HitGenInc's tweet image. Tune in for our @endpts webinar today, moderated by @AKAarsalan on how HitGen's self-service #OpenDEL can accelerate your research. Register here: webinars.endpts.com/how-could-an-o…

HitGen reposted

China’s HitGen Partners With US Arclight to Develop Central Nervous System Diseases Drugs bit.ly/38kKOef

yicaichina's tweet image. China’s HitGen Partners With US Arclight to Develop Central Nervous System Diseases Drugs bit.ly/38kKOef

Pleased to announce a collaboration with @loqus23 to address unmet medical needs associated with aberrant DNA damage repair and improve the lives of patients with devastating genetic diseases. hitgen.com/en/news-detail…

HitGenInc's tweet image. Pleased to announce a collaboration with @loqus23 to address unmet medical needs associated with aberrant DNA damage repair and improve the lives of patients with devastating genetic diseases. hitgen.com/en/news-detail…

HitGen reposted

Today Almac Discovery announce a new strategic research collaboration with @HitGenInc to further the identification of novel compounds against selected Deubiquitinating enzyme (DUB) targets. Find out more: hubs.ly/Q01bMNfm0

AlmacGroup's tweet image. Today Almac Discovery announce a new strategic research collaboration with @HitGenInc to further the identification of novel compounds against selected Deubiquitinating enzyme (DUB) targets. Find out more: hubs.ly/Q01bMNfm0

Loading...

Something went wrong.


Something went wrong.